Literature DB >> 6699852

Optimal chemotherapy for ovarian carcinoma: discussion paper.

H E Lambert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6699852      PMCID： PMC1439574          DOI： 10.1177/014107688407700112

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  17 in total

1.  Medroxyprogesterone acetate for the treatment of metastatic and recurrent ovarian carcinoma.

Authors:  G D Malkasian; D G Decker; E O Jorgensen; J H Edmonson
Journal:  Cancer Treat Rep       Date:  1977-08

2.  Progestogen therapy for ovarian carcinoma.

Authors:  H W Ward
Journal:  J Obstet Gynaecol Br Commonw       Date:  1972-06

Review 3.  Chemotherapy of ovarian cancer: past and present.

Authors:  R C Young
Journal:  Semin Oncol       Date:  1975-09       Impact factor: 4.929

4.  Debulking surgery: does it increase the quality of survival?

Authors:  J G Blythe; T P Wahl
Journal:  Gynecol Oncol       Date:  1982-12       Impact factor: 5.482

5.  The Princess Margaret Hospital study of ovarian cancer: stages I, II, and asymptomatic III presentations.

Authors:  A J Dembo; R S Bush; F A Beale; H A Bean; J F Pringle; J F Sturgeon
Journal:  Cancer Treat Rep       Date:  1979-02

6.  Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy.

Authors:  R C Young; B A Chabner; S P Hubbard; R I Fisher; R A Bender; T Anderson; R M Simon; G P Canellos; V T DeVita
Journal:  N Engl J Med       Date:  1978-12-07       Impact factor: 91.245

7.  The CHAD and HAD regimens in advanced ovarian cancer: combination chemotherapy including cyclophosphamide, hexamethylmelamine, adriamycin, and cis-dichlorodiammineplatinum(II).

Authors:  S E Vogl; M Berenzweig; B H Kaplan; M Moukhtar; W Bulkin
Journal:  Cancer Treat Rep       Date:  1979-02

8.  Epithelial carcinoma of the ovary: current strategies.

Authors:  M E Katz; P E Schwartz; D S Kapp; S Luikart
Journal:  Ann Intern Med       Date:  1981-07       Impact factor: 25.391

9.  In-vitro clonogenic assay for predicting response of ovarian cancer to chemotherapy.

Authors:  D S Alberts; S E Samon; H S Chen; E A Surwit; B Soehnlen; L Young; T E Moon
Journal:  Lancet       Date:  1980-08-16       Impact factor: 79.321

10.  Rewiew of ovarian cancer at the University of Texas Systems Cancer Center, M.D. Anderson Hospital and Tumor Institute.

Authors:  J P Smith; T G Day
Journal:  Am J Obstet Gynecol       Date:  1979-12-01       Impact factor: 8.661
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.